Ametek/$AME

1D1W1MYTD1Y5YMAX

About Ametek

Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns more than 40 autonomous industrial businesses operating across research, aerospace, energy, medical, and manufacturing. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets it operates in.
Ticker
$AME
Primary listing
NYSE
Employees
22,500

Ametek Metrics

BasicAdvanced
$54B
34.74
$6.84
0.99
$1.30
0.57%

What the Analysts think about Ametek

Analyst ratings (Buy, Hold, Sell) for Ametek stock.
Analyst projections of the future price of Ametek stock.

Bulls say / Bears say

AMETEK delivered strong Q2 execution, with record sales of $2.04 billion, up 15%, adjusted EPS up 17% to $2.09, and adjusted operating income up 18%; management raised 2026 adjusted EPS guidance to $8.20–$8.30. (SEC filing)
Demand momentum was broad-based: orders increased 28% for the second consecutive quarter, with strength across semiconductor, commercial aerospace, medtech, defense and automation markets. (SEC filing)
The completed Indicor transaction adds roughly $1.1 billion of annual sales, substantial recurring aftermarket revenue and businesses aligned with AMETEK’s mission-critical instrumentation strategy; management expects year-one cash earnings accretion and significant synergies. (SEC transaction presentation)
The $5.0 billion Indicor acquisition was funded with substantial new debt, including up to $4.0 billion of term loans and an expanded $3.5 billion revolver; variable-rate financing increases interest-rate and deleveraging risk. (SEC filing)
Indicor is expected to contribute approximately $350 million of 2026 sales and be only modestly accretive to adjusted earnings, leaving meaningful execution and integration risk relative to the $5.0 billion purchase price. (AMETEK)
Earnings quality warrants scrutiny: Q2 adjusted EPS of $2.09 included $0.32 per share of acquisition-related amortization, financing fees and integration costs, while GAAP interest expense rose to $30.1 million from $16.9 million year over year. (SEC filing)
Data summarised monthly by Lightyear AI. Last updated on 14 Sept 2026.

Ametek Financial Performance

Revenues and expenses
Income statement
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
Net income
Profit margin

Ametek Earnings Performance

Company profitability
Earnings per share
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
Expected
Surprise

Funds containing Ametek

AllEURGBPUSD
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.